A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.
A new study, published in the journal Molecular Psychiatry, found no link between genetics and the occurrence of depressive symptoms.
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.
The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.
Despite safety concerns, a new study reveals that there has been no change in the use of benzodiazepines in the elderly from 2001 to 2010.
The writings of Pies and his colleagues, I believe, provide a compelling case study of cognitive dissonance. Cognitive dissonance arises when people are presented with information that creates conflicted psychological states, challenging some belief they hold dear, and people typically resolve dissonant states by sifting through information in ways that protect their self-esteem and their financial interests. It is easy to see that process operating here.
A new study finds that clinicians’ disregard for mental health patients’ insight into their own condition may be detrimental to treatment.
Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...
New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.
If academic psychiatry is evidence-based, why did it take two decades to recognize SSRI withdrawal as widespread and chronic among patients?
In this month’s issue of the journal Brain a new study investigates whether the drugs prescribed to control seizures can increase the risk of...
An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.
A new study provides an insider’s look into how psychiatrists view the establishment of drug-free programs in Norway.
I am a former Lieutenant in the US Navy, and on August 30, I sent a letter to the US Senate and House Committees on Armed Services, and their respective committees on Veterans' Affairs. I titled the letter "Concerning Mental Health Treatment and Suicide in the United States Armed Forces and the Veteran Community." Here is what I wrote:
“This research points to the inadequacy of asking the simple question: ‘Do antidepressants work?’ Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in people’s lives.”
Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.
Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...
A group of researchers in Denmark examines what existing animal studies can tell us about the sexual side-effects of SSRI antidepressants.
Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...
Association found between long-term antipsychotic use and poorer performance on cognitive tasks in adults diagnosed with ‘schizophrenia.’
"There is a need of a shift in investments in mental health, from focusing on 'chemical imbalances' to focusing on 'power imbalances' and inequalities"
Antidepressants are commonly considered safe and effective treatments. However, research has questioned their efficacy, and now, their safety.
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.
The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.
Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.